Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Hair aging is caused by stress, hormones, inflammation, and DNA damage affecting hair growth and color.

Effective PCOS treatments require targeting specific signaling pathways.

The formulated gel is a promising treatment for alopecia areata.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Screening for iron levels in patients with hair loss may help find a genetic iron overload condition early.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

A teenager had both alopecia areata and vitiligo, which are rare to occur together.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

A woman's complete hair loss condition improved after recovering from COVID-19.

Activated PRP injections are effective in treating hair loss and improving hair density.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

Assessing CD8+ T cell levels before surgery may improve vitiligo treatment outcomes.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Non-drug therapies show promise for hair regrowth but need more research.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.